At 18% of GDP, the healthcare industry is one of the most important sectors of the U.S. economy, yet from an IT perspective, it has been stuck in the 1980s. A recent influx of $18 billion dollars from a Federal stimulus package designed to help the industry go digital, as well as a $7 Billion package to help it go wireless, has sparked a gold rush across the health IT space. Nearly all of this investment is going to create systems to collect, share, and analyze data to improve health and lower cost.
From the study of epidemics, to machine learning that can improve diagnosis and long-term disease management, to the sequencing of the human genome, we’re doing the math of life itself. This panel of practitioners will show us how this explosion of data will change healthcare forever.
Andrew Odewahn is the CTO of O’Reilly Media, where he helps define and create new products, services, and business models that will help O’Reilly continue to make the transition to an increasingly digital future. The author of two books on database development, he has experience as a software developer and consultant in a number of industries, including manufacturing, pharmaceuticals, and publishing. Andrew has an MBA from New York University and a degree in Computer Science from the University of Alabama. He’s also thru-hiked the Appalachian Trail from Georgia to Maine.
Carol is Chief Innovation and Analytics Officer of Tenzing Health, creating community-based health cooperatives that link people, organizations and resources. The future of health and well-being lies in the idea that ‘all markets are conversations’ and creating this ongoing conversation with all it implies. Tenzing’s innovations in analytics and human-centered design stimulate new notions of health, care, community and sustainability, and accelerate their integration.
Prior to joining Tenzing, Carol was vice president of R&D in Humana’s Innovation Center where she pioneered novel computational approaches in prediction, knowledge discovery and simulation. She launched Humana’s innovations in personalized medicine research and led their Health Services Research Center, emphasizing research in population health, health outcomes, health economics, drug safety and the psychology of health behavior change. Carol also launched and served on the board of Green Ribbon Health, delivering innovations in health services to seniors in Florida.
Carol served as a member of the National Committee on Vital and Health Statistics (NCVHS) and as advisor to the HRP Scientific Program Board. Carol is a fellow of the Society of Actuaries and a member of the American Academy of Actuaries.
David is the co-founder of Asthmapolis, a company that uses medication sensors and real-time information about asthma to improve management, lower costs and guide public health. He is an asthma epidemiologist and medical anthropologist by training with an interest in global respiratory health and low cost solutions to chronic respiratory disease. He was formerly an Epidemic Intelligence Service Officer with the Centers for Disease Control and Prevention, and a Robert Wood Johnson Foundation Health and Society Scholar at the University of Wisconsin School of Medicine and Public Health.
Jim Golden is a Partner and Chief Management Scientist at Accenture. Dr. Golden leads The Global Pharmaceutical Analytics Practice and supports the Global Healthcare Data Analytics Group. His work focuses on the development of data analytics strategy, platforms, offerings and solutions for Accenture’s pharmaceutical, payer, provider and government clients. His most recent work focuses on the areas of Comparative Effectiveness Research (CER) and Evidence Based Medicine (EBM) within healthcare R&D, and physician targeting and customer lifetime value for pharmaceutical commercial marketing.
Indu Subaiya, MD, MBA is co-founder of Health 2.0: User Generated Healthcare, a first-of-its-kind forum showcasing leading edge digital media, web and mobile technologies in healthcare. She is also the creator and Director of the Health 2.0 Developer Challenge and Vice President of the Society for Participatory Medicine. Most recently she was Entrepreneur-in-Residence at Physic Ventures, where she helped evaluate investment opportunities in the consumer health space. Indu also was Vice President of Healthcare and Biomedical Research at Gerson Lehrman Group, an expert network platform, where she facilitated due diligence research in the healthcare sector. Earlier in her career she served as Director of Outcomes Research at Quorum Consulting, Inc. where she conducted post-marketing clinical trials and advised life science clients on commercialization strategies. Indu received her MD from Stony Brook University School of Medicine at the State University of New York, an MBA from the Haas School of Business at the University of California, Berkeley, and a BS in Science and Technology Studies from Cornell University.
For information on exhibition and sponsorship opportunities at the conference, contact Susan Young at email@example.com
Download the Strata Sponsor/Exhibitor Prospectus
View a complete list of Strata Contacts